Gross Margin

After a transformative year with key FDA/EU approvals, Pulsenmore's financials get a one-time boost. Can it now conquer the remote prenatal care market?

Alex Oberberg joins S4 Capital's Monks as EMEA CRO, tasked with scaling AI systems and unifying marketing in a play for regional dominance.

Gateretail and JK Tech are deploying advanced agentic AI to tackle airline retail's biggest challenges: waste, stock-outs, and squeezed margins.

The logistics giant's global strategy pays off, with new regions turning a profit for the first time and Southeast Asia dominance solidifying its growth.

Chinese pet platform Boqii slashes losses by 75% despite falling revenue, betting its future on high-margin private labels and operational discipline.

Beyond TVs: TCL's record profits are fueled by a strategic pivot to AI, high-end displays, and a booming renewable energy division, reshaping its global identity.

New research on ILUMYA, LEQSELVI, and WINLEVI shows sustained efficacy and faster results, aiming to transform treatment for millions of patients.

Crypto payment giant COINPAYMENTS partners with regulated OSL Group, leveraging local infrastructure to bridge digital assets and mainstream commerce in Asia.

Allspring's closed-end funds offer tempting yields, but tiny shifts in their monthly payouts reveal a complex story of risk, return, and capital erosion.

LM Funding reports higher revenue and record Bitcoin mining but a staggering $17.9M Q4 loss reveals the harsh reality of crypto market swings.

New data shows Dizal's ZEGFROVY achieved an 81.3% response rate in a lung cancer subgroup with limited options, signaling a potential new first-line standard.

Firan Technology Group sets its Q1 earnings date. With a record 2025 behind it, all eyes are on whether it can sustain growth amid industry trends.

After a year of strategic shifts, Nortech Systems reports a strong Q4, signaling its restructuring efforts and nearshoring focus are finally paying off.

The advanced optics maker announced a stock offering to fund operations as it navigates record revenue growth alongside plummeting profitability.

After a record 2025 and claiming the #1 shaft spot at Club Champion, Newton Golf preps to show investors how physics is reshaping the golf market.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

A new report slams the FDA for blocking vital treatments with rising costs and denials, but the agency faces a complex reality of reform and internal pressure.

A Florida firm says its 15-year study proves 'Hypergrowth Stocks' are a unique asset class. But can a 40% growth metric truly redefine investing?

Cocoa prices are falling, but your chocolate bar costs more. Discover why consumers are embracing this shift by reaching for premium, pricier treats.

As Milestone Scientific prepares its year-end call, investors look for signs of a turnaround and growth for its advanced injection technology.